Market Place
Sourcing Support
All News #Library
Biotech
Realta Life Sciences Appoints Kia Motesharei, Ph.D. To Board
26 Jan 2026 //
BUSINESSWIRE
ReAlta Pharma Appoints Jonathan Rigby to Board
07 Jan 2026 //
PHARMIWEB
ReAlta Presents Phase 2 Data on Steroid-Refractory GVHD at ASH
06 Dec 2025 //
BUSINESSWIRE
Realta Pharma Names Dr. Howard Berman Executive Chairman
25 Nov 2025 //
BUSINESSWIRE
ReAlta Presents RLS-0071 Data at 2025 ASH Meeting
06 Nov 2025 //
BUSINESS WIRE
ReAlta Life Appoints Leader Ellen as Chief Business Officer
28 Jul 2025 //
BUSINESSWIRE
ReAlta`s Shows Positive Data in Acute Graft-Versus-Host Disease
08 Dec 2024 //
BUSINESSWIRE
ReAlta Life Sciences to Present RLS-0071 Data in aGVHD at ASH
05 Nov 2024 //
BUSINESSWIRE
ReAlta Announces Collaboration with the NIAID to Evaluate RLS-0071 for ARS
28 Mar 2024 //
BUSINESSWIRE
ReAlta Life Announces Dosing of First Patient in Phase 2 Trial of RLS-0071
21 Feb 2024 //
BUSINESSWIRE
ReAlta Life Sciences Receives FDA Clearance for Phase 2 Trial of RLS-0071
24 Oct 2023 //
BUSINESSWIRE
ReAlta Life Sciences Receives FDA Clearance for Phase 2 Trial of RLS-0071
06 Sep 2023 //
BUSINESSWIRE
ReAlta Life Sciences Doses First Patient in Phase 2 STAR-Study of RLS-0071
01 Aug 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.